First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous 5-fluorouracil/leucovorin (Q40580831)

From Wikidata
Jump to navigation Jump to search
scientific article published on April 2002
edit
Language Label Description Also known as
English
First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous 5-fluorouracil/leucovorin
scientific article published on April 2002

    Statements

    First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous 5-fluorouracil/leucovorin (English)
    J Cassidy
    E Van Cutsem
    E Bajetta
    M Boyer
    R Bugat
    U Burger
    A Garin
    U Graeven
    J McKendric
    J Maroun
    J Marshall
    B Osterwalder
    G Pérez-Manga
    R Rosso
    P Rougier
    R L Schilsky
    Capecitabine Colorectal Cancer Study Group
    1 April 2002
    566-575

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit